9. Blood and Nutrition - guidance

To access BNF Formulary section click on the link under BNF Section/s

To access the Guidance Document click on the highlighted text under the Title column

Use documents past their review date with Caution

BNF Section/s	Title	Issuing Body	Date of Issue	Update Due
9.1.4	Avatrombopag	High-Cost Drugs
9.1.4	Avatrombopag - Avatrombopag for treating primary chronic immune thrombocytopenia NICE TA853	NICE	Dec 2022
9.3.1	Carnitine	High-Cost Drugs
9.1.4	Fostamatinib	High-Cost Drugs
9.1.4	Fostamatinib - Fostamatinib for treating refractory chronic immune thrombocytopenia TA835	NICE	Oct 2022
9	Forceval - Kent and Medway ICB Forceval - Position Statement for Primary Care	Kent and Medway ICB	Dec 2023	Dec 2025
9.2.4	Hypomagnesaemia - Hypomagnesaemia in Adults – Primary Care Guide	Kent and Medway ICB	Aug 2023	Aug 2025
9.2.6.1	Patiromer (Veltassa) - Patiromer for treating hyperkalaemia - TA623	NICE	Feb 2020	2023
9.1.1	Roxadustat	High-Cost Drugs
9.1.1	Roxadustat (Evrenzo) - Roxadustat for treating symptomatic anaemia in chronic kidney disease TA807	NICE	Jul 2022	-
9.2.6.1	Sodium zirconium (Lokelma) - Sodium zirconium cyclosilicate for treating hyperkalaemia -TA599	NICE	Jan 2022	-
9.1.1.3	Vitamin B12 - Kent and Medway Vitamin B12 Position statement and deprescribing	Kent and Medway ICB	Jul 2023	Jul 2025
9.6	Vitamin D - KENT AND MEDWAY PRESCRIBING GUIDELINES FOR VITAMIN D IN ADULTS	Kent and Medway CCG	Dec 2020	-